내시경적 보툴리눔 독소 주입으로 치료한 윤상인두근이상증 1예

Endoscopic botulinum toxin injection in cricopharyngeal dysphagia

  • 정교태 (연세대학교 의과대학 내과학교실) ;
  • 최홍규 (연세대학교 의과대학 내과학교실) ;
  • 이기병 (연세대학교 의과대학 내과학교실) ;
  • 유정환 (연세대학교 의과대학 내과학교실) ;
  • 김지현 (연세대학교 의과대학 내과학교실) ;
  • 박윤길 (연세대학교 의과대학 재활의학교실) ;
  • 이상인 (연세대학교 의과대학 내과학교실)
  • Jung, Kyo-Tae (Department of Internal Medicine, Yonsei University College of Medicine) ;
  • Choi, Hong-Kyu (Department of Internal Medicine, Yonsei University College of Medicine) ;
  • Lee, Ki-Byung (Department of Internal Medicine, Yonsei University College of Medicine) ;
  • Yu, Jung-Hwan (Department of Internal Medicine, Yonsei University College of Medicine) ;
  • Kim, Jie-Hyun (Department of Internal Medicine, Yonsei University College of Medicine) ;
  • Park, Yoon-Ghil (Department of Rehabilitation Medicine, Yonsei University College of Medicine) ;
  • Lee, Sang-In (Department of Internal Medicine, Yonsei University College of Medicine)
  • 투고 : 2009.09.21
  • 심사 : 2009.10.09
  • 발행 : 2010.09.01

초록

보툴리눔 독소는 아칼라지아, 당뇨병성 위마비, 오디괄약근 장애, 만성 항문치열 등 다양한 소화기 질환에 사용되고 있다. 윤상인두근 기능이상은 이전에는 기계적 풍선 확장술이나 윤상인두근 절제술로 치료하였으나, 최근 윤상인두근 내 보툴리눔 독소 주입에 의해 안전하고 효과적으로 치료될 수 있음이 보고되고 있다. 본 환자는 뇌졸중에 의한 윤상인두근 장애로 연하곤란을 호소하였으며, 내시경적 보툴리눔 독소주입 이후 호전을 보였기에 이를 보고하는 바이다.

Botulinum toxin has been used to treat various gastrointestinal tract diseases such as achalasia, diabetic gastroparesis, sphincter of oddi dysfunction, and chronic anal fissures. Recently, it has also been used for the treatment of cricopharyngeal muscle dysfunction. Several studies have reported that botulinum toxin injections may be a safe and effective treatment. Previously, cricopharyngeal muscle dysfunction was treated by mechanical balloon dilation or cricopharyngeal myotomy. Here, we report a case of a 57-year-old man who presented with cricopharyngeal dysphagia due to cerebral infarction and who was successfully treated with endoscopic botulinum toxin injection.

키워드

참고문헌

  1. 서정기, 박효진, 이두연, 김기황, 오세창, 전재윤, 박인서. 윤상 인두근 운동이상증 치험 1예. 대한소화기학회지 29:247-251, 1997
  2. Murry T, Wasserman T, Carrau RL, Castillo B. Injection of botulinum toxin A for the treatment of dysfunction of the upper esophageal sphincter. Am J Otolaryngol 26:157-162, 2005 https://doi.org/10.1016/j.amjoto.2004.11.010
  3. Masiero S, Briani C, Marchese-Ragona R, Giacometti P, Costantini M, Zaninotto G. Successful treatment of long-standing post-stroke dysphagia with botulinum toxin and rehabilitation. J Rehabil Med 38:201-203, 2006 https://doi.org/10.1080/16501970500515840
  4. Moerman MB. Cricopharyngeal Botox injection: indications and technique. Curr Opin Otolaryngol Head Neck Surg 14:431-436, 2006 https://doi.org/10.1097/MOO.0b013e328010b85b
  5. Vakil N, Norris AI, Marcon N, Segalin A, Peracchia A, Bethge N, Zuccaro G, Bosco JJ, Jones WF. A prospective, randomized, controlled trial of covered expandable metal stents in the palliation of malignant esophageal obstruction at the gastroesophageal junction. Am J Gastroenterol 96:1791-1796, 2001 https://doi.org/10.1111/j.1572-0241.2001.03923.x
  6. 박현정. 보툴리눔 독소 시술. 가정의학회지 23:1181-1187, 2002
  7. Mandal A, Robinson RJ. Indications and efficacy of botulinum toxin in disorders of the gastrointestinal tract. Eur J Gastroenterol Hepatol 13:603-609, 2001 https://doi.org/10.1097/00042737-200105000-00024
  8. Blasi J, Chapman ER, Link E, Binz T, Yamasaki S, De Camilli P, Sudhof TC, Niemann H, Jahn R. Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25. Nature 365:160-163, 1993 https://doi.org/10.1038/365160a0
  9. Pamphlett R. Early terminal and nodal sprouting of motor axons after botulinum toxin. J Neurol Sci 92:181-192, 1989 https://doi.org/10.1016/0022-510X(89)90135-4
  10. Schneider I, Thumfart WF, Pototschnig C, Eckel HE. Treatment of dysfunction of the cricopharyngeal muscle with botulinum A toxin: introduction of a new, noninvasive method. Ann Otol Rhinol Laryngol 103:31-35, 1994
  11. 이청기, 김정아. 뇌졸중 환자에서 뇌 병변 위치에 따른 연하곤란의 양상. 대한재활의학회지 25:193-201, 2001
  12. Brouillette D, Martel E, Chen LQ, Duranceau A. Pitfalls and complications of cricopharyngeal myotomy. Chest Surg Clin N Am 7:457-475, 1997
  13. Brigand C, Ferraro P, Martin J, Duranceau A. Risk factors in patients undergoing cricopharyngeal myotomy. Br J Surg 94:978-983, 2007 https://doi.org/10.1002/bjs.5760
  14. 김효정, 송치욱, 정록선, 김윤배, 이정환, 진윤태, 전훈재, 엄순호, 김창덕, 류호상, 현진해. 인두성 연하곤란 환자에서 구강-인두의 운동기능 장애. 대한소화기학회지 38:9-14, 2001
  15. Ahsan SF, Meleca RJ, Dworkin JP. Botulinum toxin injection of the cricopharyngeus muscle for the treatment of dysphagia. Otolaryngol Head Neck Surg 122:691-695, 2000 https://doi.org/10.1016/S0194-5998(00)70198-7
  16. Chiu MJ, Chang YC, Hsiao TY. Prolonged effect of botulinum toxin injection in the treatment of cricopharyngeal dysphagia: case report and literature review. Dysphagia 19:52-57, 2004 https://doi.org/10.1007/s00455-003-0029-3